4 results
Approved WMOCompleted
The primary objective of this study is to evaluate efficacy and safety. Secondary objectives: PK, PK-PD.
Approved WMOCompleted
Primary: Efficacy of FF/GW642444 100/25 mcg once daily in comparison with that of FP/salmeterol 250/50 mcg twice daily during 24 weeks.Secundary: Safety and tolerability.
Not approvedWill not start
To determine the prevalence and severity of ASA-related allergic reaction in SM patients.
Approved WMOPending
To determine the prevalence and severity of aspirin-related allergic reactions in SM patients.